First Patients Enrolled in United Kingdom’s National Health Service Sponsored Clinical and Economic Study of Using MarginProbe® During Breast Surgeries

By DAY Vision | June 21, 2016

[vc_row][vc_column][vc_column_text] 18-month study to be conducted across the U.K will look at the health, cosmetic and financial impact of MarginProbe margin assessment device for lumpectomy patients Paoli, PA, June 21, 2016 – Dilon Devices announced today that the first patients have been enrolled in a United Kingdom’s National Institute of Health Research (NIHR) subdivision of…

Read More